Essential products manufactured by Sartorius, using Sü dpack polymer films made from Dow resins, support safe and effective vaccine production for global vaccine supply
The construction is scheduled to begin in the third quarter of the calendar year 2022, with expected completion in early 2024
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
Expertise in exosomes isolation and characterization will drive innovation in this field
Subscribe To Our Newsletter & Stay Updated
